Search
InMed Pharmaceuticals Inc
INMAdd to Watchlist
1.460USD
-0.040-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.09MMarket Cap
LossP/E TTM
InMed Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of InMed Pharmaceuticals Inc is 7.08, ranking 217 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.69, which is -3140.20% below the recent high of 21.07 and -54.10% above the recent low of -1.07.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.